Resources

An important part of treating Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) is learning as much as you can about the disease and treatment options that are available to you. By staying informed, you are taking an active part in helping to control your disease.

Although your doctor is the best source of information about your disease and treatments, below you will find a handful of tools and resources that you may find useful.

Learn more now:

WHAT IS RITUXAN?

Rituxan® (rituximab) is used with glucocorticoids to treat adults with Granulomatosis with Polyangiitis (GPA) (Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA).

IMPORTANT SAFETY INFORMATION

Rituxan therapy can result in serious side effects, some of which can be life threatening. These include:

  • infusion reactions
  • tumor lysis syndrome (TLS)
  • severe skin and mouth reactions
  • progressive multifocal leukoencephalopathy (PML)

Other serious, potentially life-threatening side effects are:

  • hepatitis B infection that may become active again
  • serious infections
  • heart problems
  • low blood cell counts

Common side effects include infections and infusion reactions.

Before treatment with Rituxan, patients should tell their doctor if they have an infection, including one that will not go away or that keeps coming back.

If patients experience any symptoms or side effects during or after Rituxan treatment, they should seek immediate medical attention.

These are not all of the possible side effects with Rituxan. Tell your doctor about any side effect that bothers you or that does not go away.

Please see full prescribing information, including Medication Guide.

If you have any questions about this information, be sure to discuss them with your doctor.